Overview of Cannabis including Kampo Medicine and Therapy for Treatment of Dementia: A Review

Tibor Wenger, Kazuhito Watanabe, Yui Sasaki, Keiko Kanazawa, Koichi Shimizu, Supaart Sirikantaramas, Yoshinari Shoyama, Futoshi Taura, Satoshi Morimoto, Yukihiro Shoyama*

*この論文の責任著者

研究成果: ジャーナルへの寄稿総説査読

4 被引用数 (Scopus)

抄録

Cannabis sativa L. is an annual herb oldest cultivated plants as a source of fiber since about 5000 B.C. On the other hand, the cannabis flower and seed are listed in Shennong’s classic Materia Medica approximately 2000 years ago. The formulas prescribed with cannabis in Kampo medicine have been summarized. Cannabidiol (CBD) and tetrahydrocannabinol (THC) are the major neurological and psychiatric cannabinoids, and develop to drugs. It becomes evident that the therapeutic CBD and/or THC are the important candidate of anti-dementia drugs having different mechanism for Alzheimer’s patients. Two receptors and endocannabinoids are also discussed for underlying mechanism of action. In order to promote the breeding of cannabis plant containing higher concentration of target cannabinoid the biosynthetic enzymes were isolated, cloning and the tertiary structure of THCA synthase determined by x-ray analysis resulting in the possibility of molecular breeding for cannabinoids.

本文言語英語
論文番号713228
ジャーナルFrontiers in Pharmacology
12
DOI
出版ステータス出版済み - 2022/03/01

ASJC Scopus 主題領域

  • 薬理学
  • 薬理学(医学)

フィンガープリント

「Overview of Cannabis including Kampo Medicine and Therapy for Treatment of Dementia: A Review」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル